The role of IL-17 was further proven because the treatment with nondepleting anti-CD4 monoclonal antibodies prevented the onset of arthritis in SKG mice by altering Treg/Th17 ratio in synovial tissue and draining lymph nodes (Table 1) [39]. Here, IL17A is linked to arthritic joint disease.